Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
TU2218 + Pembrolizumab for Solid Tumors
Recruiting1 awardPhase 1 & 2
San Antonio, Texas
This trial looks at safety, effectiveness and how drugs interact in advanced solid tumor patients. Phases 1b and 2a help determine drug doses and efficacy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service